Dataset Information

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors.

ABSTRACT: Using the HIV-1 protease binding mode of MK-8718 and PL-100 as inspiration, a novel aspartate binding bicyclic piperazine sulfonamide core was designed and synthesized. The resulting HIV-1 protease inhibitor containing this core showed an 60-fold increase in enzyme binding affinity and a 10-fold increase in antiviral activity relative to MK-8718.

SUBMITTER: Bungard CJ

PROVIDER: S-EPMC5733263 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors.

Bungard Christopher J CJ Williams Peter D PD Schulz Jurgen J Wiscount Catherine M CM Holloway M Katharine MK Loughran H Marie HM Manikowski Jesse J JJ Su Hua-Poo HP Bennett David J DJ Chang Lehua L Chu Xin-Jie XJ Crespo Alejandro A Dwyer Michael P MP Keertikar Kartik K Morriello Gregori J GJ Stamford Andrew W AW Waddell Sherman T ST Zhong Bin B Hu Bin B Ji Tao T Diamond Tracy L TL Bahnck-Teets Carolyn C Carroll Steven S SS Fay John F JF Min Xu X Morris William W Ballard Jeanine E JE Miller Michael D MD McCauley John A JA

ACS medicinal chemistry letters 20171113 12

Using the HIV-1 protease binding mode of MK-8718 and PL-100 as inspiration, a novel aspartate binding bicyclic piperazine sulfonamide core was designed and synthesized. The resulting HIV-1 protease inhibitor containing this core showed an 60-fold increase in enzyme binding affinity and a 10-fold increase in antiviral activity relative to MK-8718. ...[more]

PMID: 29259750

Dataset Information

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors.

Publications

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Highly potent HIV-1 protease inhibitors with novel tricyclic P2 ligands: design, synthesis, and protein-ligand X-ray studies.
| S-EPMC3800042 | biostudies-literature

Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies.
| S-EPMC12750381 | biostudies-literature

Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
| S-EPMC7425579 | biostudies-literature

Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants.
| S-EPMC5912973 | biostudies-literature

Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands.
| S-EPMC4133278 | biostudies-literature

Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation.
| S-EPMC6711809 | biostudies-literature

Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants.
| S-EPMC5605781 | biostudies-literature

Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design.
| S-EPMC12557384 | biostudies-literature

Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide Functionalities.
| S-EPMC7549267 | biostudies-literature

From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease.
| S-EPMC1255736 | biostudies-literature